Davidson Hannah, Kelly Andrew, Agrawal Rishi
Department of Cardiology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, Department of Paediatrics Adelaide, The University of Adelaide, Adelaide, South Australia, Australia.
J Paediatr Child Health. 2021 Dec;57(12):1893-1898. doi: 10.1111/jpc.15603. Epub 2021 Jun 1.
Kawasaki disease (KD) is one of the most common causes of acquired cardiac disease in children in high-income countries. The incidence of coronary artery disease (CAD), despite treatment with intravenous immunoglobulin, ranges from 5 to 20%. Determining risk factors for CAD may assist with management and reduce long-term complications.
Retrospective data were collected for all patients presenting to the Women's and Children's Hospital with a discharge diagnosis of KD over a 10.5-year period, from 2007 to 2018.
A total of 141 patients were included in the review; 101 patients fulfilled complete criteria for KD; 25 incomplete criteria and 15 did not meet criteria but were treated for KD. CAD was present in 27.7% of all patients, ranging from ectasia to giant aneurysms based on Z-scores and echocardiogram descriptions. Medium to large aneurysms accounted for 8.5% of all patients with suspected KD. Patients with CAD were more likely to: fulfil incomplete criteria (odds ratio (OR) 4.3, 95% confidence interval (CI) 1.7-10.8, P = 0.0027), be less than 12 months of age (OR 11.38, 95% CI 2.94-44.11, P = 0.0001), have CRP > 100 (OR 2.8, 95% CI 1.31-6.02, P = 0.0068) and have a delay in treatment (average day of illness prior to treatment 8.89 vs. 6.78 (OR 1.19, 95% CI 1.05-1.35, P = 0.0055)). Patients with a Kobayashi score ≥4 had a higher rate of re-treatment with intravenous immunoglobulin (OR 3.16, 95% CI 1.27-7.83, P = 0.013).
Our data are consistent with previously reported risk factors, and high rates of CAD despite standard treatment.
在高收入国家,川崎病(KD)是儿童后天性心脏病最常见的病因之一。尽管采用静脉注射免疫球蛋白进行治疗,冠状动脉疾病(CAD)的发病率仍在5%至20%之间。确定CAD的危险因素可能有助于治疗管理并减少长期并发症。
收集了2007年至2018年期间在妇女儿童医院出院诊断为KD的所有患者的回顾性数据。
本综述共纳入141例患者;101例患者符合KD的完整标准;25例符合不完全标准,15例不符合标准但接受了KD治疗。所有患者中27.7%存在CAD,根据Z评分和超声心动图描述,范围从血管扩张到巨大动脉瘤。中到大动脉瘤占所有疑似KD患者的8.5%。患有CAD的患者更有可能:符合不完全标准(比值比(OR)4.3,95%置信区间(CI)1.7 - 10.8,P = 0.0027),年龄小于12个月(OR 11.38,95% CI 2.94 - 44.11,P = 0.0001),C反应蛋白(CRP)> 100(OR 2.8,95% CI 1.31 - 6.02,P = 0.0068)以及治疗延迟(治疗前平均发病天数8.89天对6.78天(OR 1.19,95% CI 1.05 - 1.35,P = 0.0055))。小林评分≥4的患者静脉注射免疫球蛋白再治疗率更高(OR 3.16,95% CI 1.27 - 7.83,P = 0.013)。
我们的数据与先前报道的危险因素一致,且尽管采用标准治疗,CAD的发生率仍然很高。